Medpace Holdings (MEDP) Net Income towards Common Stockholders Growth (5y) (2020 - 2026)
Medpace Holdings (MEDP) Net Income towards Common Stockholders Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Medpace Holdings | 13.30 Bn | 12.64 Bn | 196.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.39% |
| Dec 31, 2025 | 21.58% |
| Sep 30, 2025 | 21.80% |
| Jun 30, 2025 | 30.22% |
| Mar 31, 2025 | 31.67% |
| Dec 31, 2024 | 33.89% |
| Sep 30, 2024 | 32.09% |
| Jun 30, 2024 | 26.33% |
| Mar 31, 2024 | 39.82% |
| Dec 31, 2023 | 26.19% |
| Sep 30, 2023 | 29.59% |
| Jun 30, 2023 | 29.81% |
| Mar 31, 2023 | 38.03% |
| Dec 31, 2022 | 30.56% |
| Sep 30, 2022 | 46.36% |
| Jun 30, 2022 | 38.88% |
| Mar 31, 2022 | 48.65% |
| Dec 31, 2021 | 70.64% |
| Sep 30, 2021 | 57.35% |
| Jun 30, 2021 | 51.75% |